TrialPloS one2013

Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age.

Elissa Malkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.